Document is current
Any future updates will be listed below
-
Authors
Ohba, Kojiro https://orcid.org/0000-0003-2841-1998
Osawa, Takahiro
Kojima, Takahiro
Hara, Tomohiko
Sugimoto, Mikio
Eto, Masatoshi
Minami, Keita
Nakai, Yasutomo
Ueda, Kosuke
Naito, Sei
Nonomura, Norio
Murai, Sachiyo
Nishiyama, Hiroyuki
Nakanishi, Hiromi
Mukae, Yuta
Mitsunari, Kensuke
Matsuo, Tomohiro
Imamura, Ryoichi
Shinohara, Nobuo
- License Information
-
More Information
Article History
Received: 10 December 2024
Accepted: 28 January 2025
First Online: 14 February 2025
Declarations
:
: Kojiro Ohba has received honoraria from BMS, Ono, and MSD. Takahiro Osawa has received honoraria from MSD. Takahiro Kojima has received honoraria from Astellas. Mikio Sugimoto has received honoraria from Janssen, Astellas, AstraZeneca, Takeda, and Pfizer. Masatoshi Eto has received honoraria from Astellas, AstraZeneca, Bayer, BMS, Eisai, Janssen, Merck, MSD, Ono, Pfizer, and Takeda; and research funding from BMS, MSD, Ono, and Takeda. Sei Naito has received honoraria from BMS. Norio Nonomura has received honoraria from Pfizer, Merck, Takeda, MSD, Ono, BMS. Nobuo Shinohara has received honoraria from Ono, BMS, Eisai, MSD and Takeda; and research funding from Ono, Takeda, and Eisai. The other authors declare no conflicts of interest.
: The Institutional Review Board of Hokkaido University Hospital (the principal institution) approved the study protocol (approval number 018–0003), as did the review boards of each of the participating hospitals.
